<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cardiovascular benefit of treating mild hypertension</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cardiovascular benefit of treating mild hypertension</h1>
<div class="graphic"><div class="figure"><div class="ttl">Cardiovascular benefit of treating mild hypertension</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Reduced incidence of fatal and total coronary heart disease (CHD) events and strokes following antihypertensive therapy in 17 controlled studies involving almost 48,000 patients with mild to moderate hypertension. The number of patients having each of these events is depicted, with active treatment lowering the incidence of coronary events by 16 percent and stroke by 40 percent. However, the absolute benefit (as shown, in percent, by the numbers at the top of the graph) was much less. Treatment for approximately four to five years prevented a coronary event or a stroke in 2 percent of patients (0.7 + 1.3), including prevention of death in 0.8 percent.</div><div class="graphic_footnotes">CVA: cerebrovascular accident (stroke).</div><div class="graphic_reference">Data from: Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578.</div><div id="graphicVersion">Graphic 52231 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
